Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572741 · ClinicalTrials.gov registry record · NA
Treating Oxidative Stress and the Metabolic Pathology of Autism
A NA study, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT00572741 is a NA study that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 39 participants.
The verdict
NCT00572741, a NA study, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Hypothesis: Many children with autism have impaired methylation and antioxidant/detoxification capacity and chronic oxidative stress. A targeted nutritional intervention that is designed to correct the metabolic imbalance will normalize their metabolic profile and improve measures of autistic behavior.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT B12
- DIETARY_SUPPLEMENT folate
- DIETARY_SUPPLEMENT B complex
- DIETARY_SUPPLEMENT vitamin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-06 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572741
The ClinicalTrials.gov registry entry for NCT00572741 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00572741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572741 about?
NCT00572741 is a clinical study titled "Treating Oxidative Stress and the Metabolic Pathology of Autism". Hypothesis: Many children with autism have impaired methylation and antioxidant/detoxification capacity and chronic oxidative stress. A targeted nutritional intervention that is designed to correct the metabolic imbalance will normalize their metabolic profile and improve measures of autistic behavi...
What is the current status of trial NCT00572741?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2008-06. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00572741?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), B12 (DIETARY_SUPPLEMENT), folate (DIETARY_SUPPLEMENT), B complex (DIETARY_SUPPLEMENT), vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00572741?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.